Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A man with skin and hair symptoms improved partially with specific treatment.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

A synthetic sandalwood odorant can boost antimicrobial production in hair follicles, making them more resistant to bacteria.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Ferulic acid may help hair grow by activating certain receptors in cells.

Pomiferin may improve skin and scalp health by boosting important protein expression.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Fexofenadine may help treat a difficult type of hair loss.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.